Compounds > 4-amino-n-(2,6-dimethylphenyl)phthalimide
Page last updated: 2024-09-03

4-amino-n-(2,6-dimethylphenyl)phthalimide and lomerizine

4-amino-n-(2,6-dimethylphenyl)phthalimide has been researched along with lomerizine in 1 studies

Compound Research Comparison

Studies
(4-amino-n-(2,6-dimethylphenyl)phthalimide)		Trials
(4-amino-n-(2,6-dimethylphenyl)phthalimide)		Recent Studies (post-2010)
(4-amino-n-(2,6-dimethylphenyl)phthalimide)		Studies
(lomerizine)		Trials
(lomerizine)		Recent Studies (post-2010) (lomerizine)
500100329

Protein Interaction Comparison

ProteinTaxonomy4-amino-n-(2,6-dimethylphenyl)phthalimide (IC50)lomerizine (IC50)
Delta-type opioid receptorMus musculus (house mouse)2.43
Voltage-dependent L-type calcium channel subunit beta-1Rattus norvegicus (Norway rat)0.09
Voltage-dependent calcium channel subunit alpha-2/delta-1Rattus norvegicus (Norway rat)0.09
Voltage-dependent N-type calcium channel subunit alpha-1BHomo sapiens (human)2.43
Voltage-dependent N-type calcium channel subunit alpha-1BRattus norvegicus (Norway rat)0.09
Prostaglandin D2 receptor 2Homo sapiens (human)0.09

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anger, T; Madge, DJ; Mulla, M; Riddall, D1

Reviews

1 review(s) available for 4-amino-n-(2,6-dimethylphenyl)phthalimide and lomerizine

ArticleYear
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
    Journal of medicinal chemistry, 2001, Jan-18, Volume: 44, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke

2001